121 related articles for article (PubMed ID: 11406220)
21. Diagnosis of chronic rejection using peritubular and glomerular capillary lesions.
Morozumi K; Oikawa T; Fukuda M; Sugito K; Takeuchi O; Oda A; Fujinami T; Takeda A; Uchida K
Transplant Proc; 1996 Feb; 28(1):508-11. PubMed ID: 8644331
[No Abstract] [Full Text] [Related]
22. The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
Jirasiritham S; Sumethkul V; Mavichak V; Chalermsanyakorn P
Transplant Proc; 2000 Nov; 32(7):2040-2. PubMed ID: 11120057
[No Abstract] [Full Text] [Related]
23. Role of acute rejection in chronic rejection.
Vanrenterghem Y
Transplant Proc; 1998 Jun; 30(4):1210-1. PubMed ID: 9636491
[No Abstract] [Full Text] [Related]
24. Interleukin-6, interleukin-8, and interleukin-10 in kidney transplantation: improved risk strategy?
Diller R; Palmes D; Dietl KH; Senninger N; Winde G; Spiegel HU
Transplant Proc; 2003 Jun; 35(4):1333-7. PubMed ID: 12826152
[No Abstract] [Full Text] [Related]
25. Correlation between Banff classification acute rejection scores and reversal of rejection.
Park KK; Kim HC; Kwon JK; Park SB; Cho WH
Transplant Proc; 1998 Nov; 30(7):3067-8. PubMed ID: 9838351
[No Abstract] [Full Text] [Related]
26. Examination of serum amyloid A protein in kidney transplant patients.
Fukuda Y; Hoshino S; Tanaka I; Yoneya T; Takeshita T; Sumimoto R; Kanbe M
Transplant Proc; 2000 Nov; 32(7):1796-8. PubMed ID: 11119942
[No Abstract] [Full Text] [Related]
27. Biopsy-proven resolution of steroid-resistant acute rejection with basiliximab therapy in a renal allograft recipient.
Goh HK; Lye WC
Transplant Proc; 2001; 33(7-8):3213-4. PubMed ID: 11750379
[No Abstract] [Full Text] [Related]
28. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
Sevmis S; Emiroglu R; Karakayali F; Yagmurdur MC; Dalgic A; Moray G; Haberal M
Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
[TBL] [Abstract][Full Text] [Related]
29. Third and fourth kidney transplant: still a reasonable option.
Izquierdo L; Peri L; Piqueras M; Revuelta I; Alvarez-Vijande R; Musquera M; Oppenheimer F; Alcaraz A
Transplant Proc; 2010 Sep; 42(7):2498-502. PubMed ID: 20832531
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?
Eberhard OK; Langefeld I; Kuse ER; Brunkhorst FM; Kliem V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
Clin Transplant; 1998 Jun; 12(3):206-11. PubMed ID: 9642511
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of slow recovery of renal function in renal transplantation.
Park JH; Yang CW; Kim YS; Moon IS; Chang YS; Koh YB; Bang BK
Transplant Proc; 1999 Nov; 31(7):2841-2. PubMed ID: 10578309
[No Abstract] [Full Text] [Related]
32. Early graft dysfunction developed within one week after renal allograft.
Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
[No Abstract] [Full Text] [Related]
33. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
[TBL] [Abstract][Full Text] [Related]
34. Successful therapy of acute vascular rejection with combined plasma-exchange and monoclonal antibody.
Gupta RK; Nampoory MR; Johny KV; Costandi JN; Nair MP; Francis I; Ninan VT
Transplant Proc; 2001 Aug; 33(5):2770-3. PubMed ID: 11498154
[No Abstract] [Full Text] [Related]
35. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.
Mulloy LL; Wright F; Hall ML; Moore M
Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541
[No Abstract] [Full Text] [Related]
36. Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept.
Carl S; Dörsam J; Mandelbaum A; Staehler G; Wiesel M
Transplant Proc; 1998 Jun; 30(4):1236-7. PubMed ID: 9636502
[No Abstract] [Full Text] [Related]
37. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
Halim MA; Al-Otaibi T; Al-Muzairai I; Mansour M; Tawab KA; Awadain WH; Balaha MA; Said T; Nair P; Nampoory MR
Transplant Proc; 2010 Apr; 42(3):801-3. PubMed ID: 20430176
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative renal biopsy and its relation to renal function at the end of the first year posttransplantation.
Vazquez MC; Schiavelli RO; Sabbatiello R; Castiglioni T; Pattin M
Transplant Proc; 1996 Feb; 28(1):372-3. PubMed ID: 8644271
[No Abstract] [Full Text] [Related]
39. Three cases of suspected antibody-mediated rejection.
Sutherland SM; Sarwal M
Clin Transpl; 2006; ():473-8. PubMed ID: 18365406
[No Abstract] [Full Text] [Related]
40. Cytomegalovirus infection in kidney transplant recipients: early diagnosis and monitoring of antiviral therapy by the antigenemia assay.
Said T; Nampoory MR; Pacsa AS; Johny KV; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2001 Aug; 33(5):2799-801. PubMed ID: 11498164
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
